Breast-Tumor-on-Chip Featuring Microfluidic-Enabled 3D Tumor Spheroid Generation and Perfusion-Based Combinatorial Drug Testing
Lab on a Chip · 2026
DOI: 10.1039/d6lc00676k ↗Kurz gefasst
Fachartikel in der Zeitschrift Lab on a Chip, 2026. Verfasst von Tsai-Yu Shih und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), presents treatment challenges because hormone-based therapies are...
Zitieren
APA
Shih, T., Yao, C., Yang, L., & Liu, C. (2026). Breast-Tumor-on-Chip Featuring Microfluidic-Enabled 3D Tumor Spheroid Generation and Perfusion-Based Combinatorial Drug Testing. Lab on a Chip. https://doi.org/10.1039/d6lc00676k
Vancouver
Shih T, Yao C, Yang L, Liu C. Breast-Tumor-on-Chip Featuring Microfluidic-Enabled 3D Tumor Spheroid Generation and Perfusion-Based Combinatorial Drug Testing. Lab on a Chip. 2026. doi:10.1039/d6lc00676k
BibTeX
@article{Shih2026,
author = {Shih, Tsai-Yu and Yao, Chao-Ling and Yang, Lee-Wei and Liu, Cheng-Hsien},
title = {Breast-Tumor-on-Chip Featuring Microfluidic-Enabled 3D Tumor Spheroid Generation and Perfusion-Based Combinatorial Drug Testing},
journal = {Lab on a Chip},
year = {2026},
doi = {10.1039/d6lc00676k}
}
EUVIMED